# Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

> **NCT06200974** · — · RECRUITING · sponsor: **British Columbia Cancer Agency** · enrollment: 100 (estimated)

## Conditions studied

- Localized Prostate Carcinoma

## Interventions

- **RADIATION:** High dose rate prostate brachytherapy

## Key facts

- **NCT ID:** NCT06200974
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2038-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06200974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06200974, "Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06200974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*